- /
- Supported exchanges
- / US
- / CSBR.NASDAQ
Champions Oncology Inc (CSBR NASDAQ) stock market data APIs
Champions Oncology Inc Financial Data Overview
Champions Oncology, Inc., a technology-enabled research company, provides technology solutions for drug discovery and development in the United States. The company provides personalized cancer care based upon the implantation of human tumors in immune-deficient mice through TumorGraft Technology Platform. It also offers translational oncology solutions that utilizes its technology platform to provide research services that assist in the drug development process of pharmaceutical and biotechnology companies. In addition, the company offers Lumin Bioinformatics, an oncology data-driven software program which contains comprehensive information derived from research services and clinical studies. It markets its products through internet and sales force to pharmaceutical and biotechnology companies. The company was formerly known as Champions Biotechnology, Inc. and changed its name to Champions Oncology, Inc. in April 2011. Champions Oncology, Inc. was incorporated in 1985 and is headquartered in Hackensack, New Jersey.
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Champions Oncology Inc (top by weight)
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Or get access to advanced financial data starting only $19.99
Get Champions Oncology Inc data using free add-ons & libraries
Get Champions Oncology Inc Fundamental Data
Champions Oncology Inc Fundamental data includes:
- Net Revenue: 60 662 K
- EBITDA: 402 K
- Earnings Per Share: 0
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
End-of-day & Earnings data
What’s included:
- Latest Release: 2026-09-10
- EPS/Forecast: -0.01
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Champions Oncology Inc News
New
Capitalize on the Global PDX Models Shift: Benchmark Charles River, Crown Bioscience, Champions Oncology, The Jackson Laboratory and Oncodesign to Secure Precision Oncology ROI
Company Logo PDX adoption is rising as pharma seeks predictive oncology models for precision medicine, biomarker discovery and drug screening, supported by sequencing advances and research partnershi...
CSBR Stock Slips Post Q1 Earnings Despite Revenue, Margin Growth
Shares of Champions Oncology, Inc. CSBR have lost 1.8% since the company reported its earnings for the quarter ended July 31, 2026. This compares with the S&P 500 Index's 0.2% rise over the same time ...
Champions Oncology signals fiscal 2027 momentum as Q1 revenue reaches $15.2M and gross margin improves to 50%
Earnings Call Insights: Champions Oncology (CSBR) Q1 fiscal 2027 MANAGEMENT VIEW * "When we spoke in July, I said fiscal '26 was an investment year and that the onus was on us to deliver in fiscal...
Champions Oncology Q1 Earnings Call Highlights
Key Points Interested in Champions Oncology, Inc.? Here are five stocks we like better. Revenue and profitability improved: First-quarter fiscal 2027 revenue rose 9% to $15.2 million, while adjusted ...
Corporate Events Calendar & News package for
Or get access to advanced financial data starting only $19.99
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.